Schabacker Matthew bought CNMD
March 2, 2026 · Form 4 insider transaction
Schabacker Matthew bought 11,646 shares of CONMED Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,646
Price
$0.00
Total value
N/A
InsiderSchabacker Matthew
Role—
CompanyCONMED Corporation (CNMD)
SecurityOptions To Purchase Common Stock
Transaction codeA: Grant or award
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after11,646
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock options were granted under CONMED Corporation Corporation's 2025 Long-Term Incentive Plan, with the stock options generally vesting in equal amounts over a four-year period with the first 25% of the stock options vesting one year after the grant date.